Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment
Sign Up to like & getrecommendations! Published in 2020 at "Cell Biochemistry and Function"
DOI: 10.1002/cbf.3461
Abstract: Chemotherapy resistance has become a hold back and major clinical challenge in osteosarcoma cancer. The alteration and subcellular distribution of apurinic/apyrimidinic endonuclease 1 (APE1) has been reported to be involved in chemotherapy resistance in many… read more here.
Keywords: chemotherapy; treatment; ape1; cytoplasmic ape1 ... See more keywords